Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOD-961 vs Glucagon for Injection in Healthy Volunteers
NCT02403648Phase 1Completed
- Sponsor
- Biodel Inc.
- Start
- Nov 2014
- Primary completion
- Mar 2015
01
Overview
Phase 1, randomised, open-label trial of BIOD-961 in hypoglycemia, sponsored by Biodel Inc. Started Nov 2014; status: completed.
02
Drugs
BIOD-961
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02403648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403648.